Plant as anticogulant/antithrombotic agent
Journal name: World Journal of Pharmaceutical Research
Original article title: Plant as anticogulant/antithrombotic agent
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Shikha Jain, CBS Dangi, Manpreet Kaur, Hardev Singh, Jaya Peter &Sushmit Kosta
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Plant as anticogulant/antithrombotic agent
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Copyright (license): WJPR: All rights reserved
Download the PDF file of the original publication
Summary of article contents:
Introduction
Thrombotic diseases, such as myocardial or cerebral infarction, pose significant health risks globally, leading to increased mortality rates. The formation of a thrombus, or blood clot, disrupts the smooth flow of blood, resulting in complications like pulmonary embolism and deep vein thrombosis. Current therapeutic avenues for managing these conditions include antithrombotic agents used to prevent thrombus formation and thrombolytic drugs that dissolve pre-existing clots. Despite their efficacy, these pharmaceutical interventions are not without limitations and can lead to severe side effects, necessitating the exploration of alternative treatment options. Traditional herbal medicine, which has been utilized for centuries, offers potential candidates for natural anticoagulant agents, meriting scientific investigation.
The Process of Blood Clotting
The blood coagulation process is a complex cascade involving various enzymes and coagulation factors that enable the formation of a fibrin meshwork to seal injuries in blood vessels. Upon encountering an injury, a series of enzymatic reactions lead to the generation of thrombin, which converts soluble plasma fibrinogen into insoluble fibrin, clumping together to form a clot. This system is divided into an initiation phase, where low amounts of thrombin are produced, and a propagation phase that features rapid thrombin generation, solid clot formation, and platelet activation. Understanding these mechanisms is critical for developing clinical treatments aimed at disrupting thrombus formation while ensuring the efficacy of hemostasis.
Categories of Antithrombotic Drugs
Antithrombotic therapeutic agents can be categorized based on their mechanism of action: anticoagulants, antiplatelet drugs, and thrombolytics. Anticoagulants prevent fibrin formation and are critical in managing thromboembolic disorders. Antiplatelet drugs inhibit platelet aggregation, reducing the risk of arterial clots. Thrombolytics promote the degradation of fibrin, actively dissolving existing clots. Each category plays a significant role in preventing vascular complications, but the risk of side effects, such as bleeding and hypersensitivity reactions, remains a concern with conventional pharmacotherapies. This highlights the necessity for safe and effective alternatives, such as plant-derived anticoagulants.
Potential of Plants as Anticoagulant Agents
Various plant species possess natural anticoagulant properties that can serve as alternative sources for drug development. Research has elucidated the mechanisms through which certain plants, such as Careya arborea and Melastoma malabathricum, exhibit anticoagulant activities by interacting with coagulation factors in the blood. For instance, the methanolic extract of Careya arborea has demonstrated efficacy in prolonging prothrombin time (PT) by reducing the activity of specific coagulation factors. This growing body of evidence suggests that phytochemicals may mitigate thromboembolic risks without the severe side effects commonly associated with synthetic anticoagulants.
Conclusion
This review underscores the importance of exploring traditional plant medicines as viable alternatives to conventional anticoagulant therapies. With increasing evidence supporting their efficacy and safety profile, herbal medicines could bridge the gap for economically disadvantaged populations seeking treatment for thrombotic disorders. Despite their historical usage, there remains a pressing need for rigorous scientific evaluation of these traditional remedies to validate their therapeutic potential and integrate them into modern pharmacotherapy. By leveraging both ancient wisdom and contemporary research, we can develop comprehensive treatment strategies that maximize patient outcomes in thrombosis prevention and management.
FAQ section (important questions/answers):
What are thrombotic diseases and their consequences?
Thrombotic diseases, such as myocardial or cerebral infarction, result from blood clots blocking vessels. They can lead to serious health issues and are significant causes of mortality worldwide.
What is the role of antithrombotic agents?
Antithrombotic agents, including anticoagulants and thrombolytics, are used to prevent or dissolve thrombosis. They help manage conditions related to blood clots but have limitations and potential side effects.
What are the types of thrombosis mentioned in this review?
The review discusses two main types of thrombosis: arterial thrombosis, which forms in arteries, and venous thrombosis, which occurs in veins, each with different physiological mechanisms and consequences.
What are common side effects of anticoagulant drugs?
Anticoagulant drugs can cause major bleeding, allergic reactions, gastrointestinal issues, fatigue, and other severe effects, making their use potentially life-threatening.
Which plants are highlighted for their anticoagulant properties?
The review lists several plants such as Careya arborea, Melastoma malabathricum, and Allium sativum that demonstrate anticoagulant effects through various mechanisms, offering potential alternatives to synthetic drugs.
What is the conclusion regarding traditional plant medicines?
The review emphasizes the need for scientific evaluation of traditional plant medicines used as anticoagulants. They offer potentially safer and cost-effective alternatives but require further research on efficacy and safety.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Plant as anticogulant/antithrombotic agent”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Blood:
Blood is a vital connective tissue that circulates throughout the body in arteries and veins. It plays a crucial role in transporting oxygen, nutrients, and waste products. In the context of thrombotic diseases, the formation of clots or thrombi within blood vessels significantly affects blood flow and can lead to serious health complications.
2) Activity:
Activity in this context refers to the biological effects that certain substances, particularly plant-based compounds, have on physiological processes such as blood coagulation. The study highlights the anticoagulant activity of various plants, indicating their potential therapeutic role in preventing clot formation and providing alternatives to synthetic drugs.
3) Drug:
A drug is a chemical substance used to diagnose, cure, treat, or prevent diseases. In the field of anticoagulation, several drugs such as heparin and warfarin are used to manage thrombotic disorders. However, the review emphasizes the limitations and side effects of these conventional drugs, prompting exploration of natural alternatives.
4) Bleeding:
Bleeding is the loss of blood from the circulatory system, which can occur internally or externally. It is a significant concern in patients using anticoagulant drugs, as these medications can increase the risk of hemorrhage. Understanding the effects of various substances on bleeding is critical for ensuring patient safety and effective treatment.
5) Shikha (Śikhā, Śikha, Sikhā, Sikha):
Shikha Jain is one of the authors of the review article discussing the role of plants as anticoagulant agents. Her contributions to the research provide insights into traditional medicine and the potential of herbal remedies in addressing thrombotic diseases, highlighting the need for scientific validation of these practices.
6) Disease:
A disease is a pathological condition characterized by a set of symptoms and signs affecting a body part or system. The review primarily discusses thrombotic diseases such as myocardial infarction and stroke, which arise from blood clot formation and are significant causes of morbidity and mortality worldwide.
7) Garlic:
Garlic, scientifically known as Allium sativum, is highlighted in the review for its anticoagulant properties. The bioactive compounds in garlic, particularly when consumed raw, can inhibit blood clot formation, making it a promising natural alternative for managing thrombotic risk without serious side effects.
8) Medicine:
Medicine refers to the science and practice of diagnosing, treating, and preventing diseases. The review examines both modern pharmaceutical drugs and traditional herbal medicines, underscoring the potential of plant-derived substances as effective therapeutic options for managing thrombotic diseases and their associated risks.
9) Table:
The table in the review summarizes data regarding the available anticoagulant drugs and their side effects. It serves as a reference point for understanding the risks associated with conventional medications, contrasting them with the potential safety of herbal alternatives derived from various plants.
10) Pain (Paiṇ):
Pain is an unpleasant sensory experience often associated with injury or illness. In the context of anticoagulants, the drugs listed may lead to side effects such as abdominal or joint pain. Understanding pain management is critical in the treatment of thrombotic diseases, as it can affect patient compliance with treatment regimens.
11) Substance:
A substance is a particular kind of matter with uniform properties. In the review, various natural substances, particularly plant extracts, are discussed for their potential anticoagulant activities. The efficacy and safety of these substances as alternatives to conventional drugs are explored in the context of thrombotic disease treatment.
12) Nausea:
Nausea is a sensation often leading to an urge to vomit, commonly associated with various medical conditions and medication side effects. Several anticoagulant drugs listed in the review can cause nausea, highlighting the importance of considering tolerability and adverse effects in pharmacological treatments for thrombotic disorders.
13) Fever:
Fever is a temporary increase in body temperature often resulting from an illness. While not directly related to anticoagulation, it can signify underlying health issues. The potential for drugs to cause systemic reactions, including fever, underscores the need for careful monitoring of patients undergoing treatment for thrombotic conditions.
14) Death:
Death is the cessation of all biological functions that sustain a living organism. The review discusses thrombotic diseases as significant contributors to mortality globally. Understanding the mechanisms of thrombosis and potential treatments is essential for reducing mortality rates associated with these conditions.
15) Ras (Rās, Rash):
A rash is a skin condition characterized by redness, swelling, and irritation. Some anticoagulant drugs can cause skin-related side effects, including rash. Awareness of these effects is important for healthcare providers in order to monitor and manage adverse reactions during anticoagulant therapy.
16) Curcuma longa:
Curcuma longa, commonly known as turmeric, is a plant used for its medicinal properties. The review highlights its anticoagulant effects, specifically through the active compound curcumin, which has been shown to inhibit clot formation, indicating its potential as a natural alternative for thrombotic diseases.
17) Turmeric:
Turmeric is a spice derived from Curcuma longa and has been recognized for its health benefits, particularly its anticoagulant properties. The review underscores the importance of turmeric as a natural remedy in managing blood coagulation, potentially reducing the risk of thromboembolic diseases.
18) Surface:
Surface references in the context of blood coagulation mechanisms denote the interactions at cell membranes where clotting factors are activated. The review discusses the role of surface phospholipids in the coagulation cascade, highlighting how they contribute to thrombus formation and the complexities of antithrombotic therapy.
19) Itching:
Itching is an uncomfortable sensation on the skin that leads to a desire to scratch. Some anticoagulant drugs may cause allergic reactions manifesting as skin itching. Monitoring for such side effects is crucial for patient safety in the administration of antithrombotic therapies.
20) Hair:
Hair, while not directly relevant to anticoagulation, is mentioned in connection with side effects related to certain anticoagulants, such as hair loss. Understanding these cosmetic implications is essential for healthcare professionals to address patient concerns during treatment for thrombotic disorders.
21) Hand:
Hand is a body part which may be referenced in clinical evaluations, diagnostic procedures, or in administering treatments. While not explicitly highlighted in thrombotic research, the hand may be involved in monitoring pulse, sensations, or during venous examinations relating to anticoagulant therapy.
22) Snake poison (Snake venom):
Snake venom contains potent anticoagulants and procoagulants that impact blood coagulation. Some plants are reported to have inhibitory effects on clotting disturbances caused by snake venoms, demonstrating their potential therapeutic role as natural antithrombotic agents in counteracting venom effects.
23) Allium sativum:
Allium sativum, known as garlic, is recognized for its health benefits, particularly its anticoagulant capabilities. The review emphasizes its ability to prevent blood clotting through various bioactive components, thereby offering a potential herbal remedy to supplement or replace conventional anticoagulants in clinical settings.
24) Phytochemical:
Phytochemicals are bioactive compounds produced by plants that possess various health-promoting properties. The review discusses various phytochemicals with recognized anticoagulant activities, emphasizing their role in alternative medicine and the importance of investigating these natural compounds for potential therapeutic applications in managing thrombotic diseases.
25) Inflammation:
Inflammation is the body's immune response to injury or infection, often causing redness and swelling. In the context of thrombosis, inflammation can promote clot formation, and some natural anticoagulants may help mitigate this response, making them valuable in preventing thromboembolic diseases.
26) Swallowing:
Swallowing refers to the process of moving food or liquid from the mouth to the stomach. While not directly linked to the review's focus, it is crucial for the administration of any oral medication, including anticoagulants, as proper swallowing ensures adequate absorption and therapeutic effects.
27) Irritation:
Irritation refers to discomfort or inflammation caused by an external agent. Some anticoagulant drugs can lead to skin irritation or gastrointestinal discomfort. Understanding these side effects is essential for practitioners to provide better patient care during anticoagulant therapy.
28) Suffering:
Suffering encompasses the experiences of pain, distress, or hardship, often related to medical conditions. The review underscores the importance of finding effective treatments for thrombotic disorders to alleviate patient suffering, particularly through the exploration of traditional plant-based therapies as alternatives to conventional drugs.
29) Toxicity:
Toxicity refers to the adverse effects from excessive exposure to a substance. Many pharmaceutical anticoagulants pose the risk of toxicity, leading to serious health issues. The review emphasizes the need to assess the safety and efficacy of herbal alternatives to avoid toxic side effects in patients.
30) Vomiting:
Vomiting is the act of expelling contents from the stomach, often a side effect of medication use. Some anticoagulant drugs can cause gastrointestinal disturbances leading to vomiting. Monitoring for such side effects is vital to ensure patient compliance and well-being during treatment.
31) Fainting (Fainted):
Fainting is a loss of consciousness due to insufficient blood flow to the brain. Patients on anticoagulant therapy may experience fainting episodes due to bleeding complications or side effects. It is essential for healthcare providers to monitor these potential risks in patients undergoing thrombotic treatment.
32) Sweating (Sweat):
Sweating is the body's response to regulate temperature or indicate stress. Some anticoagulant drugs can cause excessive sweating as a side effect. Awareness of such reactions helps healthcare providers inform patients about potential side effects and manage their overall treatment experience.
33) Bahera (Bāhēra, Bāhera):
Bahera, scientifically known as Terminalia belerica, is mentioned for its antithrombotic properties. The review emphasizes its potential therapeutic application in traditional medicine, highlighting the need for further investigation into its active components and effects on clot formation and resolution.
34) Family:
Family refers to the taxonomic grouping of related organisms. In the review, the family classification of certain plants (e.g., Gracilariaceae for algae) indicates their phylogenetic relationships and helps in understanding their medicinal properties, including anticoagulant activities relevant to thrombotic disorders.
35) Debate:
Debate signifies ongoing discussions or controversies regarding medical practices or treatments. The review indicates an ongoing debate about the role of blood coagulation factors and the efficacy of various drug therapies, underscoring the necessity of research to clarify these issues and guide clinical practice.
36) Insect:
Insects, such as leeches, are natural sources of anticoagulants. Their saliva contains substances that prevent blood clotting, which have inspired the development of synthetic anticoagulant medications. Understanding these natural mechanisms can lead to discovering new therapeutic agents for managing thrombotic conditions.
37) Satya (Satyā, Shatya):
Satya refers to Satya Prakash Singh, one of the authors of the review. His collaboration in the research highlights the collective effort in exploring the potential of traditional medicine and plant-based therapies in providing alternatives to conventional treatments for thrombotic diseases.
38) India:
India is a country rich in traditional medicine practices utilizing plant-based therapies for various ailments, including thrombotic diseases. The review emphasizes the significance of herbal medicine in India, advocating for scientific validation and research into these natural alternatives for anticoagulation.
39) Water:
Water is essential for life and is often a medium for preparing various herbal remedies. The review touches upon aqueous extracts of plants, which are used in evaluating their anticoagulant properties. The solubility of bioactive compounds in water greatly influences their efficacy.
40) Horse:
Horse may refer to the horse-tail creeper plant, scientifically known as Porana volubilis. This plant is highlighted for its anticoagulant effects, showcasing the diverse sources of natural compounds available for potential use in managing blood coagulation disorders.
41) Tanki (Ṭāṅkī, Tamki, Tāṅki, Taṅki, Ṭaṅkī):
CBS Dangi is one of the authors of the review article discussing plant-based anticoagulants. His contributions help lend credibility to the exploration of alternative therapies in treating thrombotic diseases, underscoring the importance of interdisciplinary research in this field.
42) Pata (Paṭa, Pāta, Pātā):
Pata de vaca or Bauhinia forficate is discussed for its anticoagulant properties. This traditional plant showcases the importance of exploring local flora in finding effective natural remedies to treat thrombotic disorders and offers insights into cultural medicinal uses.
43) Jaya (Jāyā, Jayā):
Jaya Peter is another author of the review who contributed to researching traditional antithrombotic agents. The collaboration highlights the collective knowledge and multidisciplinary approach necessary to explore botanical therapies in addressing thromboembolic diseases effectively.
44) Vaca (Vācā, Vacā, Vāca):
Vaca, referring to 'pata de vaca', is a plant known for its medicinal uses, particularly in addressing blood-related conditions. The review highlights its role in traditional medicine, advocating for scientific investigation of its constituents to ascertain efficacy and safety in anticoagulation.
45) Life:
Life signifies the existence of living organisms, including humans, who may suffer from thrombotic diseases. The review emphasizes the urgency of developing effective treatments to enhance life quality, focusing on both synthetic and natural medicinal approaches to manage health conditions.
46) Rich (Ṛch):
Rich refers to the diversity of phytochemicals and plant species available for exploring novel medicinal compounds. The review points to the rich heritage of traditional medicine, particularly in flora, that offers potential leads in uncovering effective natural anticoagulants for managing thromboembolic disorders.
47) Wall:
Wall in this context may refer to the vascular wall where thrombus formation occurs. Understanding how injuries to the vascular wall contribute to arterial thrombosis is crucial for developing effective antithrombotic strategies, highlighting interactions at the molecular level in coagulation.
48) Burning (Burn, Burned, Burnt):
Burn relates to discomfort or irritation, which may arise as a result of allergic reactions to medications or plant substances. Awareness of such reactions is essential in managing and advising patients regarding potential side effects of anticoagulant therapies.
49) Post:
Post refers to something occurring after a particular event. In the review context, it could denote follow-up studies needed after the initial research into plant-based anticoagulants, indicating the need for additional trials to confirm efficacy and safety in clinical applications.
50) Coma:
Coma is a state of prolonged unconsciousness that can occur due to severe health issues, including thromboembolic complications. The potential for anticoagulant drugs to affect consciousness due to bleeding risks underscores the importance of careful monitoring and risk management in treating thrombotic diseases.
51) Pur (Pūr):
Poor refers to individuals or populations with limited resources and access to healthcare. The review highlights the importance of affordable and alternative treatments like herbal medicines to assist these groups in managing thrombotic diseases effectively, emphasizing the need for cost-effective therapeutic options.
52) Lily:
Lily, possibly referring to the family of plants that includes medicinal species, emphasizes the diversity within the plant kingdom. The review suggests that many plants, including those in the lily family, may offer beneficial anticoagulant properties, warranting further investigation for therapeutic potential.
Other Science Concepts:
Discover the significance of concepts within the article: ‘Plant as anticogulant/antithrombotic agent’. Further sources in the context of Science might help you critically compare this page with similair documents:
Curcuma longa, Allium sativum, Jatropha curcas, Melastoma malabathricum, Medicinal plant, Medicinal properties, Therapeutic action, Herbal preparation, Traditional medicine, Ethical implications, In vitro, Thrombolytic agent, CVA, Deep vein thrombosis, Clotting factors, Cost factor, Anticoagulant activity, Bioactive compound, Myocardial infarction, In vivo, Anticoagulant properties, Excess sweating, Plant Extract, Pulmonary embolism, Severe bleeding, Thrombotic diseases, Blood coagulation cascade, Prothrombin activation, Platelet aggregation, Haemostasis process, Antithrombotic Therapy, Serine protease, Fibrin meshwork clot, Traditional antithrombotic drugs, Cascading reactions, Pulmonary emboli, Cardiovascular benefits, Vascular endothelial cells, Side effect, Antiplatelet drugs, Long term side effects, Low molecular weight heparin, Coagulation mechanism, Abnormal liver function, Anticoagulant drugs, Low blood pressure, Terminalia Belerica, Traditional plant medicine, Pharmacopeia, Antithrombotic agent, Thrombolytic drug, Severe allergic reaction, Allopathic system of medicine, Oral anticoagulant, Blood clot formation, Antithrombotic effect, Types of thrombosis, Process of blood clotting, Urine and vaginal bleeding, Decreased red blood cells, Sleeplessness and dizziness, Low potassium in blood, Taste perversion, Phytochemicals present in plants, Prolongation in PT, Gloriosa superb, Eichhornia crassipe, Alkali polysaccharides, Bioactive compound(s), Aqueous and ethanol extract, Natural and traditional anticoagulant agents, Antithrombotic and anticoagulant agents, Poor population, Scientifically evaluated, Invitro and invivo activity, Antiplatelet and antithrombotic activities, Antifibrinogenolytic properties, Coagulant and anticoagulant activities, Hypocoagulability issues, Acute pulmonary embolism.